Dame Emma Walmsley
Emma joined the Board as CEO Designate on 1 January 2017 and became CEO on 1 April 2017. She has been a member of the GSK Leadership Team since 2011, as the President and then CEO of GSK Consumer Healthcare. Emma will step down as CEO and from the Board on 31 December 2025.
Before being appointed as GSK’s CEO, Emma was the CEO of GSK Consumer Healthcare, a joint venture between GSK and Novartis, from its creation in March 2015. Emma joined GSK in 2010 from L’Oreal, having worked there for 17 years in a variety of roles in Paris, London, New York and Shanghai. Emma’s position as an Independent Director of Microsoft, Inc., further supplements the technology and cyber security experience she brings to the Board.
Emma holds an MA in Classics and Modern Languages from Oxford University.
External appointments:
- Independent Director, Microsoft, Inc.
Follow Emma on Linkedin and keep up to date with our 'Getting Ahead Together' film series: a spotlight on innovation, and the people who make it happen inside and outside GSK.
